{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:16:50Z","timestamp":1779362210528,"version":"3.51.4"},"reference-count":84,"publisher":"Georg Thieme Verlag KG","issue":"03\/04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Reprod Med"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Polycystic ovary syndrome (PCOS) is an endocrinologic condition affecting one in five women of reproductive age. PCOS is often characterized by disruptions to the menstrual cycle, development of male-pattern hair growth (hirsutism), and polycystic ovary morphology. Recently, PCOS has been linked to metabolic dysfunction, with 40 to 80% of women characterized as overweight or obese. Despite these well-known negative health effects of PCOS, 75% of sufferers remain undiagnosed. This is most likely due to the variability in symptom presentation and the lack of a definitive test for the condition. Metabolomics, which is a platform used to analyze and characterize a large number of metabolites, has recently been proposed as a potential tool for investigating the metabolic pathways that could be involved in the pathophysiology of PCOS. In doing so, novel biomarkers could be identified to improve diagnosis and treatment of PCOS. This review aims to summarize the findings of recent metabolomic studies that highlight metabolic-specific molecules which are deranged in PCOS, to identify potential biomarkers for the condition. Current limitations for metabolomic studies are discussed, as well as future directions to progress the field toward further validation and integration into clinical practice.<\/jats:p>","DOI":"10.1055\/s-0041-1729841","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T22:52:48Z","timestamp":1620168768000},"page":"102-110","source":"Crossref","is-referenced-by-count":15,"title":["Metabolomic Biomarkers in Polycystic Ovary Syndrome: A Review of the Evidence"],"prefix":"10.1055","volume":"39","author":[{"given":"Simon","family":"Alesi","sequence":"first","affiliation":[{"name":"Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drishti","family":"Ghelani","sequence":"first","affiliation":[{"name":"Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Mousa","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"T Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"ref2","first-page":"15","article-title":"Geographical prevalence of polycystic ovary syndrome as determined by region and race\/ethnicity","volume":"15","author":"W M Wolf","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"R L Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/obe.2007.0019","article-title":"Obesity and polycystic ovary syndrome","volume":"3","author":"S Sam","year":"2007","journal-title":"Obes Manag"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/pde.12566","article-title":"Polycystic ovary syndrome: special diagnostic and therapeutic considerations for children","volume":"32","author":"F Kamangar","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"08","key":"ref7","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/jcp.24002","article-title":"Challenges and opportunities of metabolomics","volume":"227","author":"C H Johnson","year":"2012","journal-title":"J Cell Physiol"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/1871530318666180122165415","article-title":"Emerging metabolomics biomarkers of polycystic ovarian syndrome; targeting the master metabolic disrupters for diagnosis and treatment","volume":"18","author":"M Omabe","year":"2018","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"04","key":"ref9","first-page":"81","article-title":"Hyperthecosis: an inheritable form of polycystic ovarian disease","volume":"11","author":"R S Wilroy Jr","year":"1975","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/jcem.84.1.5382","article-title":"Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families","volume":"84","author":"A Govind","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.fertnstert.2016.08.031","article-title":"Polycystic ovary syndrome and environmental toxins","volume":"106","author":"A Z Rutkowska","year":"2016","journal-title":"Fertil Steril"},{"issue":"08","key":"ref12","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/oby.20213","article-title":"Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women","volume":"21","author":"H J Teede","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/biomedicines7010005","article-title":"Hypothalamic-pituitary-ovarian axis disorders impacting female fertility","volume":"7","author":"S Mikhael","year":"2019","journal-title":"Biomedicines"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/ijem.IJEM_577_17","article-title":"Polycystic ovary syndrome and periodontal disease: underlying links\u2014a review","volume":"22","author":"S C Tanguturi","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jc.2015-4009","article-title":"Defining hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective","volume":"101","author":"R Pasquali","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10815-013-0030-1","article-title":"Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review","volume":"30","author":"B V Lakkakula","year":"2013","journal-title":"J Assist Reprod Genet"},{"issue":"09","key":"ref17","first-page":"7","article-title":"The mechanism of androgen actions in PCOS etiology","volume":"7","author":"V Rodriguez Paris","year":"2019","journal-title":"Med Sci (Basel)"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jc.2005-2501","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria","volume":"91","author":"S Franks","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"08","key":"ref19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1701-2163(16)32915-2","article-title":"Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies","volume":"30","author":"M E Lujan","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"M A Sanchez-Garrido","year":"2020","journal-title":"Mol Metab"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/jc.2006-2012","article-title":"Clinical review: identifying children at risk for polycystic ovary syndrome","volume":"92","author":"R L Rosenfield","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"05","key":"ref22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/met.2010.0039","article-title":"Polycystic ovary syndrome in the pediatric population","volume":"8","author":"A A Bremer","year":"2010","journal-title":"Metab Syndr Relat Disord"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Y Hasin","year":"2017","journal-title":"Genome Biol"},{"issue":"06","key":"ref24","first-page":"9","article-title":"Translational metabolomics: current challenges and future opportunities","volume":"9","author":"F R Pinu","year":"2019","journal-title":"Metabolites"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13063-020-4060-6","article-title":"Improving the accuracy and efficacy of diagnosing polycystic ovary syndrome by integrating metabolomics with clinical characteristics: study protocol for a randomized controlled trial","volume":"21","author":"C-M Ni","year":"2020","journal-title":"Trials"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibtech.2004.03.007","article-title":"Metabolomics by numbers: acquiring and understanding global metabolite data","volume":"22","author":"R Goodacre","year":"2004","journal-title":"Trends Biotechnol"},{"issue":"14","key":"ref27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms21144853","article-title":"Metabolomic insight into polycystic ovary syndrome-an overview","volume":"21","author":"A Rajska","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"24","key":"ref28","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.4155\/bio-2019-0014","article-title":"Analytical techniques for metabolomic studies: a review","volume":"11","author":"K Segers","year":"2019","journal-title":"Bioanalysis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: the human metabolome database for 2018","volume":"46","author":"D S Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11306-007-0077-z","article-title":"Standard reporting requirements for biological samples in metabolomics experiments: mammalian\/in vivo experiments","volume":"3","author":"J L Griffin","year":"2007","journal-title":"Metabolomics"},{"issue":"08","key":"ref31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"R S Legro","year":"2001","journal-title":"Am J Med"},{"issue":"05","key":"ref32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/09513590400027265","article-title":"Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome","volume":"20","author":"M Yilmaz","year":"2005","journal-title":"Gynecol Endocrinol"},{"issue":"05","key":"ref33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-61-5-946","article-title":"Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome","volume":"61","author":"R A Wild","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2265.2001.01228.x","article-title":"Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters","volume":"54","author":"I R Pirwany","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12944-018-0839-9","article-title":"A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS)","volume":"17","author":"M H Daghestani","year":"2018","journal-title":"Lipids Health Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"105439","DOI":"10.1016\/j.jsbmb.2019.105439","article-title":"Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review","volume":"194","author":"L Schiffer","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.numecd.2019.07.012","article-title":"Efficacy of l-carnitine supplementation for management of blood lipids: a systematic review and dose-response meta-analysis of randomized controlled trials","volume":"29","author":"M Askarpour","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.metabol.2017.03.002","article-title":"Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome","volume":"71","author":"A Y Chang","year":"2017","journal-title":"Metabolism"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/cen.13003","article-title":"Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"84","author":"M Samimi","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/09513590.2017.1290071","article-title":"Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"33","author":"H Jamilian","year":"2017","journal-title":"Gynecol Endocrinol"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1373\/clinchem.2011.176396","article-title":"Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS","volume":"58","author":"H F Escobar-Morreale","year":"2012","journal-title":"Clin Chem"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"E2269","DOI":"10.1210\/jc.2013-3942","article-title":"Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization","volume":"99","author":"Z Niu","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"22151","DOI":"10.1038\/srep22151","article-title":"An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure","volume":"6","author":"Z H Zhang","year":"2016","journal-title":"Sci Rep"},{"issue":"06","key":"ref44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/00365513.2019.1658215","article-title":"Lipidomics biomarkers in women with polycystic ovary syndrome (PCOS) using ultra-high performance liquid chromatography-quadrupole time of flight electrospray in a positive ionization mode mass spectrometry","volume":"79","author":"C L Vonica","year":"2019","journal-title":"Scand J Clin Lab Invest"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"360438","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"A Ayala","year":"2014","journal-title":"Oxid Med Cell Longev"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1038\/s41598-019-38944-6","article-title":"Alterations of sphingolipid metabolism in different types of polycystic ovary syndrome","volume":"9","author":"J Li","year":"2019","journal-title":"Sci Rep"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/JME-17-0023","article-title":"The association of the lipidomic profile with features of polycystic ovary syndrome","volume":"59","author":"L J Moran","year":"2017","journal-title":"J Mol Endocrinol"},{"issue":"03","key":"ref48","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s11306-014-0726-y","article-title":"Lipidomic analysis of plasma samples from women with polycystic ovary syndrome","volume":"11","author":"Z Haoula","year":"2015","journal-title":"Metabolomics"},{"issue":"06","key":"ref49","doi-asserted-by":"crossref","first-page":"E1088","DOI":"10.1210\/jc.2013-1295","article-title":"Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome","volume":"98","author":"U Ezeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"03","key":"ref50","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"R A Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpba.2016.01.025","article-title":"UHPLC\/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance","volume":"121","author":"Y X Chen","year":"2016","journal-title":"J Pharm Biomed Anal"},{"issue":"03","key":"ref52","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/mrd.23104","article-title":"Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry","volume":"86","author":"C Jia","year":"2019","journal-title":"Mol Reprod Dev"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1741-7015-10-153","article-title":"Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis","volume":"10","author":"Y Zhao","year":"2012","journal-title":"BMC Med"},{"issue":"02","key":"ref54","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.atherosclerosis.2007.02.012","article-title":"Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment","volume":"196","author":"M Iwase","year":"2008","journal-title":"Atherosclerosis"},{"issue":"02","key":"ref55","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4049\/jimmunol.0902257","article-title":"Signaling role for lysophosphatidylcholine acyltransferase 3 in receptor-regulated arachidonic acid reacylation reactions in human monocytes","volume":"184","author":"G P\u00e9rez-Chac\u00f3n","year":"2010","journal-title":"J Immunol"},{"issue":"49","key":"ref56","doi-asserted-by":"crossref","first-page":"33833","DOI":"10.1074\/jbc.M109.024869","article-title":"Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes","volume":"284","author":"K Yea","year":"2009","journal-title":"J Biol Chem"},{"issue":"07","key":"ref57","doi-asserted-by":"crossref","first-page":"e41456","DOI":"10.1371\/journal.pone.0041456","article-title":"Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes","volume":"7","author":"M N Barber","year":"2012","journal-title":"PLoS One"},{"issue":"03","key":"ref58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11306-010-0203-1","article-title":"Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits","volume":"6","author":"X Zhao","year":"2010","journal-title":"Metabolomics"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1743-7075-7-30","article-title":"Role of carnitine in disease","volume":"7","author":"J L Flanagan","year":"2010","journal-title":"Nutr Metab (Lond)"},{"issue":"04","key":"ref60","first-page":"392","article-title":"Effects of l\u2013carnitine on polycystic ovary syndrome","volume":"23","author":"S Salehpour","year":"2019","journal-title":"JBRA Assist Reprod"},{"issue":"05","key":"ref61","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4103\/0971-5916.171281","article-title":"Alterations in the levels of plasma amino acids in polycystic ovary syndrome--a pilot study","volume":"142","author":"S N Unni","year":"2015","journal-title":"Indian J Med Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1039\/C6MB00420B","article-title":"Serum metabolomics of Indian women with polycystic ovary syndrome using (1)h NMR coupled with a pattern recognition approach","volume":"12","author":"S RoyChoudhury","year":"2016","journal-title":"Mol Biosyst"},{"issue":"09","key":"ref63","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2337\/dc08-2075","article-title":"Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women","volume":"32","author":"K M Huffman","year":"2009","journal-title":"Diabetes Care"},{"issue":"04","key":"ref64","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00125-009-1637-8","article-title":"Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men","volume":"53","author":"E S Tai","year":"2010","journal-title":"Diabetologia"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"T J Wang","year":"2011","journal-title":"Nat Med"},{"issue":"05","key":"ref66","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","article-title":"Interplay between lipids and branched-chain amino acids in development of insulin resistance","volume":"15","author":"C B Newgard","year":"2012","journal-title":"Cell Metab"},{"issue":"06","key":"ref67","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.metabol.2015.01.008","article-title":"Effect of insulin sensitizer therapy on amino acids and their metabolites","volume":"64","author":"B A Irving","year":"2015","journal-title":"Metabolism"},{"issue":"03","key":"ref68","doi-asserted-by":"crossref","first-page":"e4993","DOI":"10.1002\/bmc.4993","article-title":"Metabolomics and correlation network analysis of follicular fluid reveals associations between l-tryptophan, l-tyrosine and polycystic ovary syndrome","volume":"35","author":"E Hou","year":"2020","journal-title":"Biomed Chromatogr"},{"issue":"04","key":"ref69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/2213235X01666131203230512","article-title":"Metabolic evidence of diminished lipid oxidation in women with polycystic ovary syndrome","volume":"2","author":"L D Whigham","year":"2014","journal-title":"Curr Metabolomics"},{"issue":"10","key":"ref70","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1093\/gbe\/evu221","article-title":"Evolution and functional implications of the tricarboxylic acid cycle as revealed by phylogenetic analysis","volume":"6","author":"J H Cavalcanti","year":"2014","journal-title":"Genome Biol Evol"},{"issue":"05","key":"ref71","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1021\/pr3000317","article-title":"Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients","volume":"11","author":"L Sun","year":"2012","journal-title":"J Proteome Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/03602530600569877","article-title":"The biological actions of dehydroepiandrosterone involves multiple receptors","volume":"38","author":"S J Webb","year":"2006","journal-title":"Drug Metab Rev"},{"issue":"02","key":"ref73","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1021\/pr401130w","article-title":"Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry","volume":"13","author":"X Zhao","year":"2014","journal-title":"J Proteome Res"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jsbmb.2018.10.012","article-title":"Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics technique","volume":"186","author":"M Buszewska-Forajta","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"01","key":"ref75","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5114\/aoms.2012.27288","article-title":"Hormonal activity in clinically silent adrenal incidentalomas","volume":"8","author":"A Babi\u0144ska","year":"2012","journal-title":"Arch Med Sci"},{"issue":"01","key":"ref76","first-page":"280","article-title":"UPLC\/Q-TOF-MS based plasma metabolomics and clinical characteristics of polycystic ovarian syndrome","volume":"19","author":"X Fan","year":"2019","journal-title":"Mol Med Rep"},{"issue":"04","key":"ref77","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EC-17-0051","article-title":"Longitudinal analyses of the steroid metabolome in obese PCOS girls with weight loss","volume":"6","author":"T Reinehr","year":"2017","journal-title":"Endocr Connect"},{"issue":"04","key":"ref78","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.mehy.2012.01.009","article-title":"Oocyte quality reflected by follicular fluid analysis in poly cystic ovary syndrome (PCOS): a hypothesis based on intermediates of energy metabolism","volume":"78","author":"B K Arya","year":"2012","journal-title":"Med Hypotheses"},{"issue":"01","key":"ref79","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13048-017-0342-3","article-title":"Follicular fluid redox involvement for ovarian follicle growth","volume":"10","author":"C Freitas","year":"2017","journal-title":"J Ovarian Res"},{"issue":"02","key":"ref80","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/humrep\/deh609","article-title":"Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries","volume":"20","author":"S Rice","year":"2005","journal-title":"Hum Reprod"},{"issue":"01","key":"ref81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12958-019-0490-y","article-title":"Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry","volume":"17","author":"Z Sun","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"issue":"08","key":"ref82","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/molehr\/gam036","article-title":"Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome","volume":"13","author":"X Ma","year":"2007","journal-title":"Mol Hum Reprod"},{"issue":"08","key":"ref83","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1021\/pr070124b","article-title":"Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms","volume":"6","author":"B Matharoo-Ball","year":"2007","journal-title":"J Proteome Res"},{"issue":"11","key":"ref84","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"R Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"03","key":"ref85","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature","volume":"91","author":"R Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Seminars in Reproductive Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1729841.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T07:44:19Z","timestamp":1698997459000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1729841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":84,"journal-issue":{"issue":"03\/04","published-online":{"date-parts":[[2021,9,16]]},"published-print":{"date-parts":[[2021,7]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1729841","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1526-8004","1526-4564"],"issn-type":[{"value":"1526-8004","type":"print"},{"value":"1526-4564","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]}}}